Anfield Capital Management, LLC Gsk PLC Transaction History

Anfield Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$38.79 - $43.16 $53,336 - $59,344	-1,375 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$36.52 - $41.46 $50,215 - $57,007	1,375 New	1,375 $55,000
Q1 2020 May 07, 2020	SELL	$32.47 - $48.83 $12,988 - $19,532	-400 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$42.0 - $48.25 $16,800 - $19,300	400 New	400 $18,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Anfield Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Anfield Capital Management, LLC with notifications on news.